Chemours (NYSE: CC) reported Q1 EPS of $0.06, $0.04 better than the analyst estimate of $0.02. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.27 billion.

For earnings history and earnings-related data on Chemours (CC) click here.